Lazar David E. → KALA BIO, Inc. KALA

Stake: 3.90% Shares: 719,404 CUSIP: 483119301 Class: Common Stock, $0.001 par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 2.37

279,430 shares short · +8.9% vs prior

Post-Filing Returns · since 2026-05-20 on KALA

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

-50.3%

+90 days

—

+180 days

—

Anchor price 1.51 on closest trading day on/after 2026-05-20. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on KALA BIO, Inc.

Filed	Form	Filer	Stake	Shares
2025-10-01	SCHEDULE	SR ONE CAPITAL MANAGEMENT, LLC	5.50%	411,000	view →
2022-05-25	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-04-01	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2020-03-23	SC	Longitude Capital Partners II, LLC	—	—	view →

Other Filings by Lazar David E.

Filed	Form	Issuer	Stake	Shares
2026-08-07	SCHEDULE 13D/A	Quantum Cyber N.V.	94.30%	477,000,000	view →
2026-04-28	SCHEDULE 13D	MAINZ BIOMED N.V. QUCY	97.40%	477,000,000	view →
2026-01-29	SCHEDULE	NovaBay Pharmaceuticals, Inc. SDEV	4.99%	6,388,000	view →
2025-03-10	SCHEDULE	FiEE, Inc. FIEE	35.10%	2,802,254	view →
2024-04-08	SC	OPGEN INC CFOR	—	—	view →
2022-07-11	SC	EQUUS TOTAL RETURN, INC. EQS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →